跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIEPAX XR TABLET 150MG - HSA Drug Approval Details
Approvals
/
HSA
/
VIEPAX XR TABLET 150MG
Approved
THERAPEUTIC
VIEPAX XR TABLET 150MG
DEXCEL PHARMA TECHNOLOGIES LTD.
🇸🇬 Health Sciences Authority
Approval Date
Jun 29, 2020
Approval ID
9b288e194a47740b
Company
DEXCEL PHARMA TECHNOLOGIES LTD.
Type
Therapeutic
Approval Details
Approval Id
9b288e194a47740b
Drug Name
VIEPAX XR TABLET 150MG
Product Name
VIEPAX XR TABLET 150MG
Approval Number
SIN15968P
Approval Date
2020-06-29
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
N06AX16
Atc Item Name
venlafaxine
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
Venlafaxine Hydrochloride eqv to Venlafaxine
150mg
VENLAFAXINE HYDROCHLORIDE EQV TO VENLAFAXINE
150 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 29, 2020
Approval ID
9b288e194a47740b
Type
Therapeutic
Back to HSA Approvals